Amy C. Moor, Director of Patient Engagement and Advocacy at Summit Therapeutics, shared a post on LinkedIn by Mark Harden, Senior Communications Professional, Content Specially/Writer in University of Colorado School of Medicine, adding:
“I have long admired and respected Dr. Ross Camidge. Today, I join the chorus of voices wishing him well as his own diagnosis with lung cancer is made public. We are all at risk for this disease and must continue in our efforts for earlier detection, better treatments and improved outcomes.
Thank you, Ross, for sharing your story.”
Quoting Mark Harden‘s post:
“One of the world’s most renowned lung cancer experts – a man who has helped countless patients live longer lives and pioneered groundbreaking treatments, and who is an inspiring leader and mentor at the University of Colorado Cancer Center and the University of Colorado Anschutz Medical Campus – has been quietly facing his own lung cancer diagnosis. Learn more here about D. Ross Camidge, MD, PhD, and his journey with advanced cancer, as ably told by my colleague Jessica Cordova.
I’ve had the privilege of interviewing Dr. Camidge and his patients a number of times. He is a man of dry wit and deep humanity, and he is a fierce champion for his patients.”
More posts featuring Amy C. Moor on OncoDaily.